The function of the EAT, an inhibitor of apotptosis, in vivo and its molecular mechanism in disease

细胞凋亡抑制剂EAT的体内功能及其在疾病中的分子机制

基本信息

项目摘要

EAT/mcl1 gene was isolated as a gene which was up-regulated at the early stage of differentiation of human embryonal carcinoma cells and belonged to the bcl-2 related gene. We have previously shown that it confered resistance to apoptosis induced by chemotherapeutic agents in cultured fibroblasts and mice overexpressing this gene exhibited hyperplasia of pancreatic islet. In order to clarify the function of the EAT/mcl-1 in vivo, we have disrupted the EAT/mcl1 gene in embryonic stem cells and generated knock out mice.We have established 11 embryonic stem cell lines in which one allele of the EAT/mcl1 exon 1 was flanked by loxP sequence and a selection casette. Three lines of mice were generated by injecting the targeted cells into murine early embryos. Crossing with Cre expressing transgenic mice, we have generated heterozygous EAT null mice and floxed mice. This heterozygous mice(EAT-/+) was morphologically indistinguishable with wild type animals. This indicates the half dose of EAT/mcl-1 is sufficient to normal development. Crossing the floxed mice with tissue specific cre expressing mice, we can nullify the EAT gene in conditional manner. We have introduced mox2 cre transgenic mice which express cre in epiblast derived embryonic tissues to knock out the EAT gene.
EAT/mcl 1基因是在人胚胎癌细胞分化早期表达上调的基因,属于bcl-2相关基因。我们以前已经证明,它赋予抵抗化疗药物诱导的细胞凋亡在培养的成纤维细胞和小鼠过表达这个基因表现出胰岛增生。为了阐明EAT/mcl-1基因在体内的功能,我们将EAT/mcl-1基因在胚胎干细胞中进行了敲除,建立了11个EAT/mcl-1基因外显子1的一个等位基因两侧带有loxP序列的胚胎干细胞系,并建立了一个筛选盒。通过将靶细胞注射到小鼠早期胚胎中产生三个品系的小鼠。与表达Cre的转基因小鼠杂交,我们产生了杂合EAT缺失小鼠和floxed小鼠。该杂合子小鼠(EAT-/+)与野生型动物在形态学上无法区分。这表明EAT/mcl-1的一半剂量足以正常发育。将floxed小鼠与组织特异性cre表达小鼠杂交,我们可以条件性地使EAT基因无效。我们已经引入了mox 2 cre转基因小鼠,其在外胚层衍生的胚胎组织中表达cre以敲除EAT基因。

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shibata, R: "Correlation between a specific Wilms tumor suppressor gene (Wt1) mutation and the histological findings in Wilms tumor (WT)"J. Med. Genet.. 39・12. E83 (2002)
Shibata, R:“特定 Wilms 肿瘤抑制基因 (Wt1) 突变与 Wilms 肿瘤 (WT) 的组织学发现之间的相关性”J. Med Genet.. 39·12 (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suzuki, S.: "Expression of interleukin-6 in cerebral neurons and ovarian cancer tissue in Trousseau syndrome"Clin. Neuropathol.. 21・5. 232-235 (2002)
Suzuki, S.:“Trousseau 综合征中脑神经元和卵巢癌组织中白细胞介素 6 的表达”,Clin. Neuropathol.. 21・5 (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Imabayashi, H: "Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis."Experimental Cell Research.. 288. 35-50 (2003)
Imabayashi, H:“通过软骨球形成和大规模 cDNA 分析表达谱来实现去分化软骨细胞的再分化和人骨髓基质细胞的软骨形成。”实验细胞研究.. 288. 35-50 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohyama, M.: "Immunologic and histopathologic characterization of active disease model mouse for pemphigus vulgaris"J. Invest. Dermatol.. 118. 199-204 (2002)
Ohyama,M.:“寻常型天疱疮活动性疾病模型小鼠的免疫学和组织病理学特征”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yabe, H.: "Matrix metalloproteinase (MMP)-1 and -3 expression in Ewing's sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo"Biochem. Biophys. Res. Commun.. 293. 61-71 (2002)
Yabe, H.:“尤文氏肉瘤中基质金属蛋白酶 (MMP)-1 和 -3 的表达可能是由于体内 MMP 调节元件与特定融合蛋白的可及性丧失所致”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UMEZAWA Akihiro其他文献

UMEZAWA Akihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UMEZAWA Akihiro', 18)}}的其他基金

Identification of cardiomyogenic factor in terms of cell-based therapy/regenerative medicine
细胞治疗/再生医学中心肌生成因子的鉴定
  • 批准号:
    22390072
  • 财政年份:
    2010
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of human cells as feeder cells of human embryonic stem cells
建立人类细胞作为人类胚胎干细胞的饲养细胞
  • 批准号:
    21659092
  • 财政年份:
    2009
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification of human cardiomyogenic factor
人类心肌生成因子的鉴定
  • 批准号:
    18390116
  • 财政年份:
    2006
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of osteogenic factor (5) in the KUSA-A1 osteoblasts
KUSA-A1 成骨细胞中成骨因子 (5) 的鉴定
  • 批准号:
    11557021
  • 财政年份:
    1999
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anti-apoptotic function of EAT/mcl-1 on diseases
EAT/mcl-1对疾病的抗凋亡作用
  • 批准号:
    11670192
  • 财政年份:
    1999
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular diagnosis of pediatric solid tumor
小儿实体瘤的分子诊断
  • 批准号:
    09670204
  • 财政年份:
    1997
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
  • 批准号:
    32070202
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    40 万元
  • 项目类别:

相似海外基金

Development of a new solid tritium breeder blanket
新型固体氚增殖毯的研制
  • 批准号:
    2908923
  • 财政年份:
    2027
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Studentship
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
  • 批准号:
    2734768
  • 财政年份:
    2026
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Studentship
REU Site: Microbial Biofilm Development, Resistance, & Community Structure
REU 网站:微生物生物膜的发展、耐药性、
  • 批准号:
    2349311
  • 财政年份:
    2025
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Continuing Grant
SoundDecisions - Musical Listening, Decision Making, And Equitable Development In The Mekong Delta
SoundDecisions - 湄公河三角洲的音乐聆听、决策和公平发展
  • 批准号:
    EP/Z000424/1
  • 财政年份:
    2025
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Research Grant
Bio-MATSUPER: Development of high-performance supercapacitors based on bio-based carbon materials
Bio-MATSUPER:开发基于生物基碳材料的高性能超级电容器
  • 批准号:
    EP/Z001013/1
  • 财政年份:
    2025
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Fellowship
Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
  • 批准号:
    10101986
  • 财政年份:
    2024
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Collaborative R&D
HURR — Platform Development
HURR – 平台开发
  • 批准号:
    10103254
  • 财政年份:
    2024
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Investment Accelerator
Automatic battery swapping cabinet development for scalability of e-mobility in Uganda
自动电池交换柜开发,以提高乌干达电动汽车的可扩展性
  • 批准号:
    10080435
  • 财政年份:
    2024
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Collaborative R&D
Development of digital diagnostics services for Parkinson’s disease
开发帕金森病数字诊断服务
  • 批准号:
    10086932
  • 财政年份:
    2024
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Collaborative R&D
RestoreDNA: Development of scalable eDNA-based solutions for biodiversity regulators and nature-related disclosure
RestoreDNA:为生物多样性监管机构和自然相关披露开发可扩展的基于 eDNA 的解决方案
  • 批准号:
    10086990
  • 财政年份:
    2024
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了